logo
Select company
Select metric
0%Cash to Assets Ratio
VS
Market
1
Sector
0
Industry
2
History
25
$ 1.79Close
$ 0.57 - $ 5.29 52-Week Range
Ticker Information

Ticker

CTOR

Company Name

CITIUS ONCOLOGY INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

CITIUS ONCOLOGY INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CTOR - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 91.71M$ 1120%
3/31/2025$ 91.44M$ 1120%
12/31/2024$ 90.48M$ 1120%
9/30/2024$ 84.37M$ 1120%
6/30/2024$ 50.01M$ 00%
3/31/2024$ 48.68M$ 33.33K0.07%
12/31/2023$ 72.62M$ 32.75K0.05%
9/30/2023$ 70.71M$ 26.52K0.04%
6/30/2023$ 69.85M$ 370.1K0.53%
3/31/2023$ 68.82M$ 120.38K0.17%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CITIUS ONCOLOGY INC is calculated as follows: CashnEq [ $ 0 ] / Assets [ $ 210.58K ]
(=) Cash to Assets [ 0% ]

CTOR - Cash to Assets Ratio, Last 5 years

0%

Minimum

Jun 30, 2022

0.53%

Maximum

Jun 30, 2023

0.1%

Average

0%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.83% with a standard deviation of 9.6%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.89%
average9.83%
median6.44%
std9.6%